Eli Lilly Corp. buy BMO Capital Markets
Start price
06.11.25
/
50%
€803.70
Target price
06.11.26
€955.79
Performance (%)
-3.73%
Price
30.03.26
€773.70
Summary
This prediction is currently active. With a performance of -3.73%, the BUY prediction by BMO_Capital_Markets is trending in the wrong direction. This prediction currently runs until 06.11.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -2.919% | -2.919% |
| iShares Core DAX® | -0.479% | -12.062% |
| iShares Nasdaq 100 | -3.377% | -5.130% |
| iShares Nikkei 225® | -0.143% | -12.633% |
| iShares S&P 500 | -2.266% | -5.049% |
Comments by BMO_Capital_Markets for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at BMO Capital Markets from $930.00 to $1,100.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€690.00
20.10.25
20.10.25
€797.57
20.10.26
20.10.26
12.13%
30.03.26
30.03.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€842.00
03.07.24
03.07.24
€928.23
03.07.25
03.07.25
-21.39%
04.07.25
04.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€936.94
01.05.25
01.05.25
-2.30%
02.05.25
02.05.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€666.00
07.02.24
07.02.24
€802.46
07.02.25
07.02.25
28.09%
08.02.25
08.02.25